This paper appears in the following:
- Keystone: Tau, Huntingtin—Do Prion-like Properties Play a Role in Disease?
- Structure-Based Approach Yields Tau Inhibitors
- Tau Biomarkers—More Informative Fragments in Spinal Fluid?
- Monomeric Seeds and Oligomeric Clouds—Proteopathy News from AAIC
- From New Tau Structure, Bona Fide Aggregation Inhibitors?
- Mounting Modifications Move Tau Toward Aggregation in Alzheimer’s Brain